Keep pulling the thread on Sam Ro.
Mike Wilson of Morgan Stanley predicts S&P 500 earnings per share will rise 17% in 2026 and another 12% in 2027.
Eli Lilly's market capitalization surpassed one trillion dollars this year, making it the world's largest healthcare company.
Mark Rowan of Apollo Global Management stated that his firm is in "risk reduction mode" due to high asset prices, sticky long-term rates, and enhanced geopolitical risk.
Netflix made a surprise acquisition bid for HBO, challenging a potential deal with Paramount.
Robinhood's stock was the top performer in the S&P 500 for the year, with a peak gain of 250%.
Berkshire Hathaway has increased its stakes in Japan's five largest trading houses to over 9% in each, including Mitsubishi, Mitsui, Sumitomo, Marubeni, and Itochu.
RBC's Lori Calvasina advises viewing Wall Street strategist price targets as a "compass" for market direction rather than a "GPS" for a precise number.
Wall Street strategists' year-end S&P 500 targets for 2026 range from 7,100 to 8,000, implying returns between 3.3% and 16.4%.
A study by Bespoke Investment Group found that the average Wall Street strategist price target since 2000 has been for an 8.9% gain, with a margin of error of approximately 14 percentage points.
According to research by Ryan Detrick of Carson Group, the S&P 500 has only delivered an annual price return between 8% and 10% four times since 1950.
Consensus estimates from Wall Street strategists call for 14% earnings growth for the S&P 500 in 2026.
Research from Sam Stovall indicates that the average intra-year drawdown for the S&P 500 during midterm election years since 1946 has been 18%.